Prevalence of vitamin D deficiency in patients with type 2 diabetes and its relationship with glycemic control

Aim: The aim of our study is to investigate serum 25-hyrdoxy (OH) vitamin D levels in patients with type 2 diabetes, determine the prevalence of vitamin D deficiency, and reveal the potential relationship between vitamin D deficiency and glycemic control.Material and Methods: A total of 100 patients (50 females, 50 males) diagnosed with type 2 DM were included in the study. Data used in the study were retrospectively acquired from the records in the files of patients who had presented to the General Internal Medicine polyclinic and clinic at Firat University Hospital.Results: Mean vitamin D levels were determined as 11.8 ± 5,8 nmol/l in females and 13.5 ± 7.3 nmol/l in males. 57 patients (57%) in total demonstrated vitamin D deficiency. Vitamin D deficiency was detected in 31 (62%) female patients and 26 (52%) male patients. A significant negative correlation was determined between diabetic patients with and without vitamin D deficiency with regard to HbA1c, fasting blood glucose, post-prandial blood glucose (p0.05).A significant negative correlation was determined between diabetic patients with and without vitamin D deficiency with regard to BMI and patient weight (p

PDF

___

1. Fidan F, Alkan BM, Tosun A. Çağın Pandemisi: D vitamini eksikliği ve yetersizliği. Türk Osteoporoz Dergisi 2014;20:71-4.
2. Wacker M, Holick MF. Vitamin D-effects on skeletal and extraskeletal health and the need for supplementation. Nutrients 2013;5:111-48.
3. Tellioğlu A, Başaran S. Güncel bilgiler ışığında vitamin D. Arşiv Kaynak Tarama Dergisi 2013;22:259-71.
4. Badawi A, Sayegh S, Sadoun E, et al. Relationship between insulin resistance and plasma vitamin D in adults. Diabetes Metab Syndr Obes 2014;7:297-303.
5. Zhou J, Chen H, Wang Z, et al. Effects of vitamin D supplementation on insulin resistance in patients with type 2 diabetes mellitus. Zhonghua Yi Xue Za Zhi 2014;94:3407-10.
6. Wiseman H. Vitamin D is a membrane antioxidant: ability to inhibit iron-dependent lipid peroxidation in liposomes compared to cholesterol, ergosterol, and tamoxifen and relevance to anticancer action. FEBS Lett 1993;326:285-8.
7. Oren M, Rotter V. Introduction: p53 the first twenty years. Cell Mol Life Sci 1999;55:9-11.
8. Stivelman E, Retnakaran R. Role of vitamin D in the pathophysiology and treatment of type 2 diabetes. Curr Diab Rev 2012;8:42-7.
9. Pittas AG, Lau J, Hu FB, et al. The role of vitamin D and calcium in type 2 diabetes. a systematic review and meta analysis. J Clin Endocrinol Metab 2007;92:2017-29.
10. Holick MF. Vitamin D deficiency. New Engl J Med 2007;357:266-81.
11. Palomer X, Gonzales-Clemente JM, Blanco Vaca F, et al. Role of Vitamin D in the pathogenezis of type 2 diabetes mellitus. Diabetes Obes Metab 2008;10:185-97.
12. George PS, Pearson ER, Witham MD. Effect of vitamin D supplementation on glycaemic control and insülin resistance: a systematic review and meta- analysis. Diab Med 2012;29:e142-50.
13. Segal S, Lloyd S, Sherman N, et al. Postprandial changes in cytosolic free calcium and glucose uptake in adipocytes in obesity and non-insulin dependent diabetes mellitus. Horm Res 1990;34:39-44.
14. Ohno Y, Suzuki H, Yamakawa H, et al. Impaired insulin sensitivity in young, lean normotensive offspring of essential hypertensives: possible role of disturbed calcium metabolism. J Hypertens 1993;11:421-6.
15. Zemel MB. Nutritional and endocrine modulation of intracellular calcium: implications in obesity, insülin resistance and hypertension. Mol Cell Biochem 1998;188:129-36.
16. Alvarez JA, Ashraf A. Role of Vitamin D in Insulin Secretion and Insulin Sensitivity for Glucose Homeostasis. Int J Endocrinol 2010;2010:351385.
17. Targher G, Bertolini L, Padovani R ve ark. Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin Endocrinol (Oxf) 2006;65:593-7.
18. Suzuki A, Kotake M, Ono Y, ve ark. Hypovitaminosis D in type 2 diabetes mellitus: association with microvascular complications and type of treatment. Endocr J 2006;53:503-10.
19. Di Cesar DJ, Ploutz-Snyder R, Weinstock RS, ve ark. Vitamin D deficiency is more common in type 2 than in type 1 diabetes. Diabetes Care 2006;29:174.
20. Isaia G, Giorgino R, Adami S. High prevalence of hypovitaminosis D in female type 2 diabetic population. Diabetes Care 2001;24:1496.
21. Pittas AG, Lau J, Hu FB ve ark, The role of vitamin d and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007;92:2017-29.
22. Witham MD, Dove FJ, Dryburgh M, ve ark. The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia 2010;53:2112-9.
23. Wortsman J, Matsuoka LY, Chen TC, ve ark. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000;72:690-3.
24. Ramakrishnan S, Bhansali A, Bhadada SK, ve ark. Vitamin D Status and its seasonal variability in young healthy adults in an asian indian urban population. Endocr Pract 2011;17:185-91.
25. Scragg R, Camargo CA Jr. Frequency of leisure-time physical activity and serum 25-hydroxyvitamin D levels in the US population: results from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2008;168:577-86.